A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers

Background and Objective: Dextromethorphan/quinidine (DMQ) is the first agent indicated for the treatment of pseudobulbar affect. Dextromethorphan, the active ingredient, is a low-affinity, uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. This study evaluated the potential for a drug-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Laura E., Schoedel, Kerri A., Bartlett, Cynthia, Sellers, Edward M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714141/
https://www.ncbi.nlm.nih.gov/pubmed/22712629
http://dx.doi.org/10.1007/BF03261905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714141/
https://www.ncbi.nlm.nih.gov/pubmed/22712629
http://dx.doi.org/10.1007/BF03261905

Ejemplares similares